Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO

Overview of attention for article published in Frontiers in Pharmacology, October 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 33 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 8,479 followers.

Open Access UCL Research: Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO - UCL Discovery https://t.co/K1yVB2scgP

04 Mar 2021

Reply Repost Favourite

New Research: Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO https://t.co/zevOc5p4UY #pharmacology

22 Nov 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.